Personal information

Emails & domains

Verified email domains

Websites & social links

UCL IRIS Profile

Other IDs

Scopus Author ID: 7102816362
ResearcherID: B-3452-2015
Loop profile: 506693
Scopus Author ID: 57196221455

Countries

United Kingdom

Activities

Collapse all

Employment (4)

University College London School of Pharmacy: London, London, GB

2013-10-21 to present | Professor in Computational Biophysics (Biological and pharmaceutical Chemistry)
Employment
Source: Self-asserted source
Shozeb Haider

Queens University Belfast School of Biological Sciences: Belfast, Belfast, GB

2011-01-01 to 2013-09-30 | Senior Lecturer (Centre for Cancer Research and Cell Biology)
Employment
Source: Self-asserted source
Shozeb Haider

University College London School of Pharmacy: London, London, GB

2006-01-01 to 2010-12-01 | Senior Research Fellow (Pharmaceutical and Biological Chemistry)
Employment
Source: Self-asserted source
Shozeb Haider

University of Oxford: Oxford, Oxfordshire, GB

2003-01-01 to 2005-12-31 | Research Fellow (Biochemistry)
Employment
Source: Self-asserted source
Shozeb Haider

Education and qualifications (1)

Institute of Cancer Research: London, GB

1999 to 2003 | PhD (Structural Biology)
Education
Source: Self-asserted source
Shozeb Haider

Professional activities (5)

Royal Society of Chemistry: London, London, GB

Fellow
Distinction
Source: Self-asserted source
Shozeb Haider

Royal Asiatic Society: London, London, GB

Fellow
Invited position
Source: Self-asserted source
Shozeb Haider

Higher Education Academy: York, GB

Fellow
Distinction
Source: Self-asserted source
Shozeb Haider

Biochemical Society GB: London, GB

Membership
Source: Self-asserted source
Shozeb Haider

American Chemical Society: Washington D.C., District of Columbia, US

2018-01-01 to present
Membership
Source: Self-asserted source
Shozeb Haider

Funding (3)

Challenges in β lactamase mediate resistance

2019-02 to 2023-12 | Grant
National Institute of Allergy and Infectious Diseases (Md., Md., US)
GRANT_NUMBER:

2R01AI063517-11A1
Source: Self-asserted source
Shozeb Haider

Small molecule inhibitors of the anti-apoptotic FLIP-FADD protein-protein interaction for the treatment of non-small cell lung cancer

2012-08 to 2015-08 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

099470/Z/12/Z
Source: Self-asserted source
Shozeb Haider
grade
Preferred source (of 2)‎

Development of small molecule legumain inhibitors for treatment of poor prognosis cancer

2011-11 to 2012-11 | Grant
Invest Northern Ireland (Belfast, GB)
GRANT_NUMBER:

RD0212890
Source: Self-asserted source
Shozeb Haider
How many people are using ORCID?